All trans-retinoic acid (ATRA) induces re-differentiation of early transformed breast epithelial cells

International Journal of Oncology

Volumn 45, Issue 6, 2014, Pages 1831-1842

  Arisi, Maria F ^a   Starker, Rebecca A ^a   Addya, Sankar ^a   Huang, Yong ^b   Fernandez, Sandra V ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Branching; Breast cancer; Retinoic acid; Transformation; Vitamin A

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; COLLAGEN; ESTRADIOL; HERMES ANTIGEN; RETINOIC ACID; TRANSCRIPTION FACTOR ETS 2;

ARTICLE; BRANCHING MORPHOGENESIS; BREAST CANCER; BREAST CANCER CELL LINE; BREAST EPITHELIUM; CANCER GROWTH; CELL DIFFERENTIATION; CELL INVASION; CELL ISOLATION; CELL STRAIN MCF 10F; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALIGNANT TRANSFORMATION; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; TRANSFORMED CELL; UPREGULATION; BREAST; CELL LINE; CELL TRANSFORMATION; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; CANCER STAGING; CELL REDIFFERENTIATION; CHEMOPROPHYLAXIS; GENE EXPRESSION PROFILING; MAMMARY GLAND; NUCLEOTIDE SEQUENCE;

BREAST; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; TRETINOIN;

EID: 84899566586     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2354     Document Type: Article

References (36)

1. Theodosiou M, Laudet V and Schubert M: From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell Mol Life Sci 67: 1423-1445, 2010.
2. Duester G: Retinoic acid synthesis and signaling during early organogenesis. Cell 134: 921-931, 2008.
3. Mongan NP and Gudas LJ: Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 75: 853-870, 2007.
4. Connolly R, Nguyen NK and Sukumar S: Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Clin Cancer Res 19: 1651-1659, 2013.
5. Bushue N and Wan YJ: Retinoid pathway and cancer therapeutics. Adv Drug Deliv Rev 62: 1285-1298, 2010.
6. Aagaard MM, Siersbaek R and Mandrup S: Molecular basis for gene-specific transactivation by nuclear receptors. Biochim Biophys Acta 1812: 824-835, 2011.
7. Tsai MJ and O'Malley BW: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63: 451-486, 1994.
8. Rochette-Egly C and Germain P: Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl Recept Signal 7: e005, 2009.
9. Heyman RA, Mangelsdorf DJ, Dyck JA, et al: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68: 397-406, 1992.
10. Garattini E, Gianni M and Terao M: Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents. Vitam Horm 75: 301-354, 2007.
11. Zanardi S, Serrano D, Argusti A, Barile M, Puntoni M and Decensi A: Clinical trials with retinoids for breast cancer chemoprevention. Endocr Relat Cancer 13: 51-68, 2006.
12. Seewaldt VL, Johnson BS, Parker MB, Collins SJ and Swisshelm K: Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 6: 1077-1088, 1995.
13. Swisshelm K, Ryan K, Lee X, Tsou HC, Peacocke M and Sager R: Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ 5: 133-141, 1994.
14. Widschwendter M, Berger J, Muller HM, Zeimet AG and Marth C: Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer. J Mammary Gland Biol Neoplasia 6: 193-201, 2001.
15. Russo J, Fernandez SV, Russo PA, et al: 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 20: 1622-1634, 2006.
16. Huang Y, Fernandez SV, Goodwin S, et al: Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res 67: 11147-11157, 2007.
17. Fernandez SV and Russo J: Estrogen and xenoestrogens in breast cancer. Toxicol Pathol 38: 110-122, 2010.
18. Hebner C, Weaver VM and Debnath J: Modeling morphogenesis and oncogenesis in three-dimensional breast epithelial cultures. Annu Rev Pathol 3: 313-339, 2008.
19. Snider KE, Ehya H, Russo J and Fernandez SV: NRG1 and RARB hypermethylation in breast cancer progression. Proceedings of the ACCR 102nd Anual Meeting, Orlando, FL. Cancer Res 71 (Suppl 1): abs. 75, 2011.
20. Glass CK and Rosenfeld MG: The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121-141, 2000.
21. Hartman HB, Yu J, Alenghat T, Ishizuka T and Lazar MA: The histone-binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3. EMBO Rep 6: 445-451, 2005.
22. Lefebvre B, Ozato K and Lefebvre P: Phosphorylation of histone H3 is functionally linked to retinoic acid receptor beta promoter activation. EMBO Rep 3: 335-340, 2002.
23. McKenna NJ and O'Malley BW: Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474, 2002.
24. Rochette-Egly C: Dynamic combinatorial networks in nuclear receptor-mediated transcription. J Biol Chem 280: 32565-32568, 2005.
25. Chen H, Lin RJ, Xie W, Wilpitz D and Evans RM: Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98: 675-686, 1999.
26. Bhat-Nakshatri P, Goswami CP, Badve S, Sledge GW Jr and Nakshatri H: Identification of FDA-approved drugs targeting breast cancer stem cells along with biomarkers of sensitivity. Sci Rep 3: 2530, 2013.
27. Gudas LJ: Retinoids induce stem cell differentiation via epigenetic changes. Semin Cell Dev Biol 24: 701-705, 2013.
28. Zhang XK, Liu Y and Lee MO: Retinoid receptors in human lung cancer and breast cancer. Mutat Res 350: 267-277, 1996.
29. Hua S, Kittler R and White KP: Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 137: 1259-1271, 2009.
30. Soprano DR and Soprano KJ: Pharmacological doses of some synthetic retinoids can modulate both the aryl hydrocarbon receptor and retinoid receptor pathways. J Nutr 133: 277S-281S, 2003.
31. Murphy KA, Quadro L and White LA: The intersection between the aryl hydrocarbon receptor (AhR)- and retinoic acid-signaling pathways. Vitam Horm 75: 33-67, 2007.
32. Hail N Jr, Kim HJ and Lotan R: Mechanisms of fenretinide-induced apoptosis. Apoptosis 11: 1677-1694, 2006.
33. McCormick DL, Becci PJ and Moon RC: Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2). Carcinogenesis 3: 1473-1476, 1982.
34. McCormick DL and Moon RC: Antipromotional activity of dietary N-(4-hydroxyphenyl)retinamide in two-stage skin tumorigenesis in CD-1 and SENCAR mice. Cancer Lett 31: 133-138, 1986.
35. Moon RC, Pritchard JF, Mehta RG, Nomides CT, Thomas CF and Dinger NM: Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor. Carcinogenesis 10: 1645-1649, 1989.
36. Pollard M, Luckert PH and Sporn MB: Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl) retinamide. Cancer Res 51: 3610-3611, 1991.